Edit |   |
---|---|
Antigenic Specificity | ANGPT2 & VEGFA, Human (Faricimab biosimilar) |
Clone | Faricimab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa lambda |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human ANGPT2 & VEGFA Recombinant Antibody (Faricimab). Faricimab (INN) is a bispecific monoclonal antibody that is being investigated for diabetic macular edema. This drug is being developed by Hoffmann-La Roche. As of 2018, faricimab is undergoing Phase III trials. |
Immunogen | n/a |
Other Names | Anti-ANGPT2 & VEGFA Recombinant Antibody, Research Grade Faricimab, Anti-Human ANGPT2 & VEGFA Recombinant Antibody(Faricimab), RG7716, RO6867461, Antibody Drug Analogues, Monoclonal Antibody, YR1492, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1607793-29-2 |
Catalog # | YR1492 |
Price | please inquire |
Order / More Info | ANGPT2 & VEGFA, Human (Faricimab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |